BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
DRD2
,
nitric oxide metabolic process
,
Inflammatory disorder
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
calmidazolium
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
MT1F
HMOX1
EGR1
MT1X
MT1G
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
HALLMARK_TNFA_SIGNALING_VIA_NFKB
NAGASHIMA_NRG1_SIGNALING_UP
NAGASHIMA_EGF_SIGNALING_UP
PODAR_RESPONSE_TO_ADAPHOSTIN_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Dynamics and structural changes of calmodulin upon interaction with the antagonist calmidazolium.
Calmidazolium induces a decrease in nicotine-induced currents and intracellular calcium levels after…
Down Regulation of Catsper1 Expression by Calmodulin Inhibitor (Calmidazolium): Possible Implication…
Performance of a scalable RNA extraction-free transcriptome profiling method for adherent cultured h…
Attenuation of calmodulin regulation evokes Ca2+ oscillations: evidence for the involvement of intra…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for calmidazolium
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ